Yongguo Li
Shanghai, 201306, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Robust Rear-View Human Tracking for Robotic Visual Sensing: A Spatiotemporal Prediction and Multi-Modal Fusion Approach.
Journal: Sensors (Basel, Switzerland)
Published: March 15, 2026
Increasing in vivo drug exposure levels of compound WX-081 (sudapyridine) when used in combination with clofazimine or clarithromycin.
Journal: Microbiology spectrum
Published: February 26, 2026
Therapeutic management of PI3Kα inhibitor-induced hyperglycemia with a novel glucokinase activator: Advancing the Frontier of PI3Kα inhibitor therapy.
Journal: Molecular metabolism
Published: January 21, 2025
Bactericidal and sterilizing activity of sudapyridine-clofazimine-TB47 combined with linezolid or pyrazinamide in a murine model of tuberculosis.
Journal: Antimicrobial agents and chemotherapy
Published: May 01, 2024
Safety, pharmacokinetics, and food effect of sudapyridine (WX-081), a novel anti-tuberculosis candidate in healthy Chinese subjects.
Journal: Clinical and translational science
Published: August 04, 2023
In Vitro Activity of the Sudapyridine (WX-081) against Non-Tuberculous Mycobacteria Isolated in Beijing, China.
Journal: Microbiology spectrum
Published: October 17, 2022
Discovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent.
Journal: Bioorganic & medicinal chemistry letters
Published: April 24, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026